Literature DB >> 34048309

Understanding progressive multifocal leukoencephalopathy: links between milky-way appearance and mismatch T2/FLAIR.

Emiliano Ruiz Romagnoli1, Manuel Perez Akly1, Luis A Miquelini1, Jorge Funes1, Tatiana Gillanders1, Cristina Besada1.   

Abstract

BACKGROUND: Magnetic resonance imaging is essential to diagnose progressive multifocal leukoencephalopathy. The broad radiological spectrum may partially be explained by genetic viral mutations and their differential neurotropism. Recent pharmacovigilance-magnetic resonance imaging studies have provided new insight into pathophysiology and radiological markers of early stages. However, how lesions evolve and why certain anatomical locations are more frequently affected remains unknown. We aim to describe a new sign - T2/fluid-attenutated inversion recovery mismatch - as a complementary marker of cavitated lesions and propose a link with the milky-way appearance, a key early sign. Furthermore, we hypothesise viral dissemination routes.
METHODS: We conducted a retrospective longitudinal study from January 2010 to January 2020, to analyse clinical and magnetic resonance imaging features of 13 progressive multifocal leukoencephalopathy individuals at the symptomatic stage (mean age 58.3 years (SD ± 16.8) - 61.5% were women).
RESULTS: The most prevalent pathology was HIV (61.5%) and motor deficit prevailed regarding other symptoms (76.9%). Frontal lobes (76.9%), middle cerebellar peduncle (61.5%), cerebellum (61.5%), and pons (53.8%) were most commonly affected, and the cortico-ponto-cerebellar pathway seemed involved in these patients. Five patients had a pure radiological pattern. Milky-way appearance was the most frequent radiological sign (58.3%). Five patients with milky-way appearance had concomitantly T2/fluid-attenuated inversion recovery mismatch (P = 0.02). This sign showed high sensitivity and specificity (100-71%, P = 0.02) to assess evolved lesions besides diffusion.
CONCLUSION: The possible tract-dependent spread, as well as clinical and genetic, have implications on the MRI variability of progressive multifocal leukoencephalopathy. The milky-way appearance could reflect a transitional phase towards evolved lesions, the latter demonstrated by T2/fluid-attenuated inversion recovery mismatch. Both could be key magnetic resonance imaging signs to diagnose progressive multifocal leukoencephalopathy at the symptomatic stage.

Entities:  

Keywords:  Progressive multifocal leukoencephalopathy; magnetic resonance imaging; milky-way appearance; mismatch T2/FLAIR

Mesh:

Year:  2021        PMID: 34048309      PMCID: PMC8649185          DOI: 10.1177/19714009211019374

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  33 in total

1.  Progressive multifocal leukoencephalopathy with selective involvement of the pyramidal tracts.

Authors:  Alexander Semmler; Horst Urbach; Thomas Klockgether; Michael Linnebank
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

2.  The 'across the pons' sign: A possible novel radiographic finding in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  A Budhram; J B Pelikan; M Kremenchutzky; M Sharma
Journal:  J Neurol Sci       Date:  2017-02-10       Impact factor: 3.181

3.  "Barbell Sign": A Diagnostic Imaging Finding in Progressive Multifocal Leukoencephalopathy.

Authors:  A Fourie Bezuidenhout; Savvas Andronikou; Christelle Ackermann; Anne-Marie Du Plessis; Derik Basson; Rafeeque A Bhadelia
Journal:  J Comput Assist Tomogr       Date:  2018 Jul/Aug       Impact factor: 1.826

4.  Spreading along white matter tracts?--A case of progressive multifocal leukoencephalopathy with unusual MRI presentation.

Authors:  Daniel Zeller; Falko Markulin; Camelia-Maria Monoranu; László Solymosi; Guido Stoll
Journal:  Clin Neurol Neurosurg       Date:  2012-07-15       Impact factor: 1.876

5.  Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.

Authors:  Martijn T Wijburg; Iris Kleerekooper; Birgit I Lissenberg-Witte; Marlieke de Vos; Clemens Warnke; Bernard M J Uitdehaag; Frederik Barkhof; Joep Killestein; Mike P Wattjes
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

6.  Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier.

Authors:  Moti L Chapagain; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

7.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

8.  MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.

Authors:  Mike P Wattjes; Martijn T Wijburg; Anke Vennegoor; Birgit I Witte; Marlieke de Vos; Nancy D Richert; Bernard M J Uitdehaag; Frederik Barkhof; Joep Killestein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-09-14       Impact factor: 10.154

9.  JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.

Authors:  Xin Dang; Christian Wüthrich; Jennifer Gordon; Hirofumi Sawa; Igor J Koralnik
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

10.  Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.

Authors:  Daisuke Ono; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoko Mori; Keiko Ichinose; Mutsufusa Watanabe; Tohru Tanizawa; Takanori Yokota; Toshiki Uchihara; Hiroto Fujigasaki
Journal:  Neuropathology       Date:  2019-06-02       Impact factor: 1.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.